(+)-lariciresinol increases expression ISO RGD:730873 6480464 lariciresinol results in increased expression of ANXA1 protein CTD PMID:27417256 (-)-alpha-phellandrene increases expression ISO RGD:730873 6480464 alpha phellandrene results in increased expression of ANXA1 mRNA CTD PMID:25075043 (-)-demecolcine increases expression ISO RGD:730873 6480464 Demecolcine results in increased expression of ANXA1 mRNA CTD PMID:23649840 (-)-lariciresinol increases expression ISO RGD:730873 6480464 lariciresinol results in increased expression of ANXA1 protein CTD PMID:27417256 (R)-noradrenaline multiple interactions ISO RGD:10164 6480464 ANXA1 affects the reaction [Norepinephrine results in decreased secretion of IL6 protein] CTD PMID:16835395 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ANXA1 mRNA CTD PMID:26776438 1,1-dichloroethene increases expression ISO RGD:10164 6480464 vinylidene chloride results in increased expression of ANXA1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:10164 6480464 ethylene dichloride results in decreased expression of ANXA1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:10164 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANXA1 mRNA CTD PMID:22206623 1,4-phenylenediamine increases expression ISO RGD:730873 6480464 4-phenylenediamine results in increased expression of ANXA1 mRNA CTD PMID:16314067 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:730873 6480464 Dinitrochlorobenzene results in increased expression of ANXA1 mRNA CTD PMID:16314067 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ANXA1 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:10164 6480464 Ethinyl Estradiol results in increased expression of ANXA1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANXA1 mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO RGD:730873 6480464 Estradiol results in increased expression of ANXA1 mRNA CTD PMID:23373633 17beta-estradiol decreases expression ISO RGD:730873 6480464 Estradiol results in decreased expression of ANXA1 mRNA CTD PMID:31614463 17beta-estradiol increases expression ISO RGD:10164 6480464 Estradiol results in increased expression of ANXA1 mRNA CTD PMID:19484750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:730873 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10164 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA CTD PMID:15591033 , PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA1 mRNA CTD PMID:20959002 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10164 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730873 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10164 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA1 mRNA CTD PMID:15667827 , PMID:19770486 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:10164 6480464 Trinitrobenzenesulfonic Acid results in increased expression of ANXA1 mRNA CTD PMID:17982090 2-hydroxypropanoic acid increases expression ISO RGD:730873 6480464 Lactic Acid results in increased expression of ANXA1 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ANXA1 protein CTD PMID:26072098 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of ANXA1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ANXA1 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:730873 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ANXA1 mRNA CTD PMID:33476716 4,4'-sulfonyldiphenol increases expression ISO RGD:730873 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects methylation ISO RGD:10164 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ANXA1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10164 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ANXA1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects expression ISO RGD:10164 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of ANXA1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:10164 6480464 Fenretinide results in decreased expression of ANXA1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:730873 6480464 Decitabine affects the expression of ANXA1 mRNA CTD PMID:23300844 5-azacytidine decreases expression EXP 6480464 Azacitidine results in decreased expression of ANXA1 protein CTD PMID:17105402 5-fluorouracil affects response to substance ISO RGD:730873 6480464 ANXA1 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 , PMID:16217747 5-fluorouracil decreases expression ISO RGD:730873 6480464 Fluorouracil results in decreased expression of ANXA1 protein CTD PMID:15352031 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ANXA1 mRNA CTD PMID:24780913 , PMID:30047161 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12376462 , PMID:22248470 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 9-cis-retinoic acid decreases expression ISO RGD:730873 6480464 Alitretinoin results in decreased expression of ANXA1 protein CTD PMID:28886987 acrolein multiple interactions ISO RGD:730873 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ANXA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ANXA1 mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO RGD:730873 6480464 Aflatoxin B1 affects the expression of ANXA1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ANXA1 mRNA CTD PMID:25378103 aflatoxin B1 increases expression ISO RGD:730873 6480464 Aflatoxin B1 results in increased expression of ANXA1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression ISO RGD:10164 6480464 Aflatoxin B1 results in decreased expression of ANXA1 mRNA CTD PMID:19770486 all-trans-4-oxoretinoic acid increases expression ISO RGD:730873 6480464 4-oxoretinoic acid results in increased expression of ANXA1 mRNA CTD PMID:15982314 all-trans-retinoic acid multiple interactions ISO RGD:730873 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of ANXA1 mRNA] CTD PMID:16140955 all-trans-retinoic acid multiple interactions ISO RGD:10164 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of ANXA1 mRNA more ... CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:730873 6480464 Tretinoin results in decreased expression of ANXA1 mRNA, Tretinoin results in decreased expression of ANXA1 protein CTD PMID:23830798 , PMID:28886987 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ANXA1 mRNA CTD PMID:24977338 all-trans-retinoic acid increases expression ISO RGD:730873 6480464 Tretinoin results in increased expression of ANXA1 mRNA CTD PMID:15982314 more ... alpha-phellandrene increases expression ISO RGD:730873 6480464 alpha phellandrene results in increased expression of ANXA1 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:730873 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ANXA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ANXA1 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ANXA1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANXA1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANXA1 mRNA CTD PMID:30779732 aniline increases nitrosation EXP 6480464 aniline results in increased nitrosation of ANXA1 protein CTD PMID:21708182 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of ANXA1 mRNA CTD PMID:23038007 aristolochic acid A increases expression ISO RGD:730873 6480464 aristolochic acid I results in increased expression of ANXA1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:10164 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ANXA1 mRNA CTD PMID:23650126 arotinoid acid multiple interactions ISO RGD:730873 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane decreases expression ISO RGD:730873 6480464 Arsenic results in decreased expression of ANXA1 protein CTD PMID:19818359 arsenic atom decreases expression ISO RGD:730873 6480464 Arsenic results in decreased expression of ANXA1 protein CTD PMID:19818359 arsenite(3-) affects activity EXP 6480464 arsenite affects the activity of ANXA1 protein CTD PMID:20655937 arsenite(3-) multiple interactions EXP 6480464 arsenite affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] CTD PMID:20655937 arsenous acid multiple interactions ISO RGD:730873 6480464 Arsenic Trioxide results in increased expression of and results in increased secretion of ANXA1 protein CTD PMID:18081892 arsenous acid decreases expression ISO RGD:730873 6480464 Arsenic Trioxide results in decreased expression of ANXA1 protein CTD PMID:25258189 arsenous acid increases response to substance ISO RGD:730873 6480464 ANXA1 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:25983101 arsenous acid increases expression ISO RGD:730873 6480464 Arsenic Trioxide results in increased expression of ANXA1 mRNA, Arsenic Trioxide results in increased expression of ANXA1 protein CTD PMID:22521957 , PMID:25983101 ATP multiple interactions EXP 6480464 [Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein more ... CTD PMID:20655937 Bardoxolone methyl affects expression ISO RGD:730873 6480464 bardoxolone methyl affects the expression of ANXA1 mRNA CTD PMID:34480604 benzatropine multiple interactions ISO RGD:730873 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of ANXA1 protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:10164 6480464 Benzo(a)pyrene results in decreased expression of ANXA1 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:730873 6480464 Benzo(a)pyrene results in increased expression of ANXA1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:730873 6480464 Benzo(a)pyrene results in increased methylation of ANXA1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:730873 6480464 Benzo(a)pyrene results in decreased expression of ANXA1 mRNA CTD PMID:30453624 benzo[a]pyrene increases expression ISO RGD:10164 6480464 Benzo(a)pyrene results in increased expression of ANXA1 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:730873 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA1 mRNA CTD PMID:18164116 bilirubin IXalpha decreases expression ISO RGD:730873 6480464 Bilirubin results in decreased expression of ANXA1 mRNA CTD PMID:20196124 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of ANXA1 mRNA CTD PMID:25031359 bis(2-ethylhexyl) phthalate increases expression ISO RGD:730873 6480464 Diethylhexyl Phthalate results in increased expression of ANXA1 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ANXA1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:730873 6480464 bisphenol A results in decreased expression of ANXA1 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:10164 6480464 bisphenol A results in decreased expression of ANXA1 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANXA1 mRNA CTD PMID:29552716 , PMID:32145629 bisphenol A multiple interactions ISO RGD:10164 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ANXA1 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:10164 6480464 bisphenol A results in increased expression of ANXA1 mRNA CTD PMID:30951980 , PMID:32156529 Bisphenol B increases expression ISO RGD:730873 6480464 bisphenol B results in increased expression of ANXA1 protein CTD PMID:34186270 bisphenol F decreases expression ISO RGD:730873 6480464 bisphenol F results in decreased expression of ANXA1 mRNA CTD PMID:33476716 bisphenol F increases expression ISO RGD:730873 6480464 bisphenol F results in increased expression of ANXA1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:10164 6480464 bisphenol F results in increased expression of ANXA1 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:10164 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA1 mRNA CTD PMID:30951980 cadmium atom decreases expression ISO RGD:730873 6480464 Cadmium results in decreased expression of ANXA1 mRNA CTD PMID:16439709 cadmium atom multiple interactions ISO RGD:730873 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANXA1 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANXA1 protein CTD PMID:31738976 , PMID:33040242 cadmium atom multiple interactions EXP 6480464 Cadmium affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] CTD PMID:20655937 cadmium atom affects activity EXP 6480464 Cadmium affects the activity of ANXA1 protein CTD PMID:20655937 cadmium atom increases expression ISO RGD:730873 6480464 Cadmium results in increased expression of ANXA1 mRNA CTD PMID:21120746 cadmium dichloride decreases expression ISO RGD:730873 6480464 Cadmium Chloride results in decreased expression of ANXA1 protein CTD PMID:24419708 cadmium dichloride multiple interactions ISO RGD:730873 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANXA1 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANXA1 protein CTD PMID:31738976 , PMID:33040242 cadmium dichloride increases expression ISO RGD:730873 6480464 Cadmium Chloride results in increased expression of ANXA1 protein CTD PMID:24527689 cadmium sulfate increases expression ISO RGD:730873 6480464 cadmium sulfate results in increased expression of ANXA1 mRNA CTD PMID:12064557 , PMID:14676411 calcium atom affects activity EXP 6480464 Calcium affects the activity of ANXA1 protein CTD PMID:20655937 calcium(0) affects activity EXP 6480464 Calcium affects the activity of ANXA1 protein CTD PMID:20655937 carbamazepine affects expression ISO RGD:730873 6480464 Carbamazepine affects the expression of ANXA1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:730873 6480464 Nanotubes, Carbon results in increased expression of ANXA1 protein CTD PMID:22157353 carbon nanotube increases expression ISO RGD:10164 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of ANXA1 mRNA CTD PMID:19395590 carrageenan affects response to substance ISO RGD:10164 6480464 ANXA1 protein affects the susceptibility to Carrageenan CTD PMID:12475898 carrageenan multiple interactions ISO RGD:10164 6480464 ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan] CTD PMID:12475898 CHIR 99021 multiple interactions ISO RGD:730873 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloropicrin increases expression ISO RGD:730873 6480464 chloropicrin results in increased expression of ANXA1 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:10164 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA1 mRNA CTD PMID:20938992 chromium(6+) multiple interactions EXP 6480464 chromium hexavalent ion affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] CTD PMID:20655937 chromium(6+) affects activity EXP 6480464 chromium hexavalent ion affects the activity of ANXA1 protein CTD PMID:20655937 Cinobufagin increases expression ISO RGD:730873 6480464 cinobufagin results in increased expression of ANXA1 mRNA CTD PMID:35447139 cisplatin increases expression ISO RGD:730873 6480464 Cisplatin results in increased expression of ANXA1 mRNA, Cisplatin results in increased expression of ANXA1 protein CTD PMID:21924258 , PMID:27594783 cisplatin affects expression ISO RGD:730873 6480464 Cisplatin affects the expression of ANXA1 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:10164 6480464 Cisplatin results in increased expression of ANXA1 mRNA CTD PMID:21151649 cisplatin affects response to substance ISO RGD:730873 6480464 ANXA1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clozapine decreases expression ISO RGD:730873 6480464 Clozapine results in decreased expression of ANXA1 protein CTD PMID:34122009 copper atom affects binding ISO RGD:730873 6480464 ANXA1 protein binds to Copper CTD PMID:14534351 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ANXA1 mRNA CTD PMID:30556269 copper(0) affects binding ISO RGD:730873 6480464 ANXA1 protein binds to Copper CTD PMID:14534351 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ANXA1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:730873 6480464 Copper Sulfate results in increased expression of ANXA1 mRNA CTD PMID:19549813 cortisol multiple interactions ISO RGD:730873 6480464 [4-(2-(5 more ... CTD PMID:25763180 , PMID:34480604 cortisol increases expression ISO RGD:730873 6480464 Hydrocortisone results in increased expression of ANXA1 mRNA CTD PMID:25763180 crocidolite asbestos decreases expression ISO RGD:10164 6480464 Asbestos, Crocidolite results in decreased expression of ANXA1 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ANXA1 mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:730873 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of ANXA1 protein CTD PMID:34122009 cyclosporin A increases expression ISO RGD:730873 6480464 Cyclosporine results in increased expression of ANXA1 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:10164 6480464 Cyclosporine results in decreased expression of ANXA1 mRNA CTD PMID:19770486 D-penicillamine decreases expression EXP 6480464 Penicillamine results in decreased expression of ANXA1 mRNA CTD PMID:19575532 D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of ANXA1 mRNA CTD PMID:19575532 DDT decreases expression EXP 6480464 DDT results in decreased expression of ANXA1 mRNA CTD PMID:30207508 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of ANXA1 mRNA CTD PMID:22228705 dexamethasone multiple interactions ISO RGD:730873 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:10807665 , PMID:7522859 dexamethasone affects response to substance EXP 6480464 ANXA1 protein affects the susceptibility to Dexamethasone CTD PMID:15472012 dexamethasone multiple interactions ISO RGD:10164 6480464 ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan] CTD PMID:12475898 dexamethasone affects response to substance ISO RGD:10164 6480464 ANXA1 protein affects the susceptibility to Dexamethasone CTD PMID:12475898 dexamethasone increases phosphorylation ISO RGD:730873 6480464 Dexamethasone results in increased phosphorylation of ANXA1 protein CTD PMID:10807665 dexamethasone increases localization ISO RGD:730873 6480464 Dexamethasone results in increased localization of ANXA1 protein modified form CTD PMID:10807665 dexamethasone increases expression ISO RGD:730873 6480464 Dexamethasone results in increased expression of ANXA1 protein CTD PMID:10807665 dextran sulfate multiple interactions ISO RGD:10164 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANXA1 mRNA CTD PMID:29950665 diallyl trisulfide increases expression ISO RGD:730873 6480464 diallyl trisulfide results in increased expression of ANXA1 mRNA, diallyl trisulfide results in increased expression of ANXA1 protein CTD PMID:16344271 diarsenic trioxide multiple interactions ISO RGD:730873 6480464 Arsenic Trioxide results in increased expression of and results in increased secretion of ANXA1 protein CTD PMID:18081892 diarsenic trioxide increases expression ISO RGD:730873 6480464 Arsenic Trioxide results in increased expression of ANXA1 mRNA, Arsenic Trioxide results in increased expression of ANXA1 protein CTD PMID:22521957 , PMID:25983101 diarsenic trioxide increases response to substance ISO RGD:730873 6480464 ANXA1 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:25983101 diarsenic trioxide decreases expression ISO RGD:730873 6480464 Arsenic Trioxide results in decreased expression of ANXA1 protein CTD PMID:25258189 diazinon affects expression EXP 6480464 Diazinon affects the expression of ANXA1 mRNA CTD PMID:22546817 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ANXA1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:10164 6480464 Dibutyl Phthalate results in increased expression of ANXA1 mRNA CTD PMID:17361019 , PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of ANXA1 mRNA CTD PMID:22546817 diethyl maleate affects expression ISO RGD:730873 6480464 diethyl maleate affects the expression of ANXA1 mRNA CTD PMID:34480604 diethyldithiocarbamic acid increases expression EXP 6480464 Ditiocarb results in increased expression of ANXA1 mRNA CTD PMID:16603213 dimethylarsinous acid increases expression ISO RGD:730873 6480464 dimethylarsinous acid results in increased expression of ANXA1 mRNA CTD PMID:23487506 dioxygen multiple interactions ISO RGD:730873 6480464 Oxygen affects the reaction [AHR protein results in increased expression of ANXA1 mRNA] CTD PMID:27103661 disodium selenite increases expression ISO RGD:730873 6480464 Sodium Selenite results in increased expression of ANXA1 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ANXA1 mRNA CTD PMID:21551480 , PMID:25152437 diuron decreases expression ISO RGD:730873 6480464 Diuron results in decreased expression of ANXA1 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:730873 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:730873 6480464 Doxorubicin affects the expression of ANXA1 protein CTD PMID:29385562 doxorubicin decreases expression ISO RGD:730873 6480464 Doxorubicin results in decreased expression of ANXA1 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:730873 6480464 Doxorubicin results in increased expression of ANXA1 mRNA CTD PMID:30031762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ANXA1 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:730873 6480464 entinostat results in decreased expression of ANXA1 mRNA CTD PMID:26272509 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ANXA1 mRNA CTD PMID:16946407 ethanol multiple interactions ISO RGD:10164 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ANXA1 mRNA CTD PMID:30517762 ethanol decreases expression ISO RGD:10164 6480464 Ethanol results in decreased expression of ANXA1 mRNA CTD PMID:15513904 ethyl methanesulfonate decreases expression ISO RGD:730873 6480464 Ethyl Methanesulfonate results in decreased expression of ANXA1 mRNA CTD PMID:23649840 eurycomanone decreases expression ISO RGD:730873 6480464 eurycomanone results in decreased expression of ANXA1 mRNA, eurycomanone results in decreased expression of ANXA1 protein CTD PMID:21903368 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of ANXA1 mRNA CTD PMID:21852994 flurbiprofen increases expression ISO RGD:10164 6480464 Flurbiprofen results in increased expression of ANXA1 mRNA CTD PMID:16949054 fluticasone affects localization ISO RGD:730873 6480464 Fluticasone affects the localization of ANXA1 protein CTD PMID:15753895 folic acid multiple interactions ISO RGD:10164 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 formaldehyde increases expression ISO RGD:730873 6480464 Formaldehyde results in increased expression of ANXA1 mRNA CTD PMID:23649840 , PMID:27664576 furan increases expression EXP 6480464 furan results in increased expression of ANXA1 mRNA CTD PMID:27387713 genistein multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of ANXA1 mRNA, [Genistein co-treated with Methoxychlor] results in decreased expression of ANXA1 mRNA CTD PMID:21782745 , PMID:25031359 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ANXA1 protein CTD PMID:22649256 genistein decreases expression ISO RGD:730873 6480464 Genistein results in decreased expression of ANXA1 protein CTD PMID:20884965 genistein multiple interactions ISO RGD:730873 6480464 ESR2 promotes the reaction [Genistein results in decreased expression of ANXA1 protein] CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANXA1 mRNA, Gentamicins results in increased expression of ANXA1 protein CTD PMID:22061828 , PMID:33387578 glycidyl methacrylate increases expression ISO RGD:730873 6480464 glycidyl methacrylate results in increased expression of ANXA1 protein CTD PMID:36641056 glyphosate increases expression ISO RGD:730873 6480464 glyphosate results in increased expression of ANXA1 mRNA CTD PMID:37047296 glyphosate affects methylation EXP 6480464 glyphosate affects the methylation of ANXA1 gene CTD PMID:35440735 graphite increases expression ISO RGD:730873 6480464 Graphite results in increased expression of ANXA1 protein CTD PMID:22157353 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of ANXA1 mRNA CTD PMID:15159207 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of ANXA1 protein CTD PMID:23178681 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA1 protein] CTD PMID:23178681 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA1 protein] CTD PMID:23178681 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ANXA1 protein CTD PMID:23178681 hydroquinone increases expression ISO RGD:730873 6480464 hydroquinone results in increased expression of ANXA1 mRNA CTD PMID:31256213 ibuprofen affects expression ISO RGD:730873 6480464 Ibuprofen affects the expression of ANXA1 mRNA CTD PMID:17070997 inulin multiple interactions ISO RGD:10164 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ANXA1 mRNA CTD PMID:36331819 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of ANXA1 mRNA CTD PMID:19821111 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of ANXA1 mRNA CTD PMID:19821111 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 isoprenaline multiple interactions ISO RGD:10164 6480464 ANXA1 affects the reaction [Isoproterenol results in decreased secretion of IL6 protein] CTD PMID:16835395 isoprenaline increases expression ISO RGD:10164 6480464 Isoproterenol results in increased expression of ANXA1 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:730873 6480464 Ivermectin results in decreased expression of ANXA1 protein CTD PMID:32959892 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of ANXA1 mRNA CTD PMID:25787151 kojic acid decreases expression ISO RGD:730873 6480464 kojic acid results in decreased expression of ANXA1 mRNA CTD PMID:16595896 L-ascorbic acid multiple interactions ISO RGD:730873 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA, [Quercetin co-treated with Ascorbic Acid] results in increased expression of ANXA1 mRNA CTD PMID:17639512 , PMID:34480604 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of ANXA1 mRNA CTD PMID:15372504 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:730873 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:10164 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA1 mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of ANXA1 mRNA, lead acetate results in decreased expression of ANXA1 protein CTD PMID:11578147 lead(0) affects activity EXP 6480464 Lead affects the activity of ANXA1 protein CTD PMID:20655937 lead(0) multiple interactions EXP 6480464 Lead affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] CTD PMID:20655937 lead(II) chloride increases expression ISO RGD:730873 6480464 lead chloride results in increased expression of ANXA1 protein CTD PMID:24419708 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of ANXA1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:730873 6480464 ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] more ... CTD PMID:21777521 lipopolysaccharide decreases response to substance EXP 6480464 ANXA1 protein results in decreased susceptibility to Lipopolysaccharides CTD PMID:16835395 lipopolysaccharide multiple interactions ISO RGD:10164 6480464 ANXA1 protein affects the reaction [Lipopolysaccharides affects the secretion of IL6 protein] more ... CTD PMID:16633358 , PMID:21777521 lithocholic acid increases expression ISO RGD:10164 6480464 Lithocholic Acid results in increased expression of ANXA1 mRNA CTD PMID:20359477 magnesium atom multiple interactions EXP 6480464 [Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein more ... CTD PMID:20655937 mercury dibromide increases expression ISO RGD:730873 6480464 mercuric bromide results in increased expression of ANXA1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:730873 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:10164 6480464 3-hydroxyacetanilide results in decreased expression of ANXA1 mRNA CTD PMID:18544908 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ANXA1 mRNA CTD PMID:30047161 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of ANXA1 mRNA CTD PMID:21782745 methyl methanesulfonate decreases expression ISO RGD:730873 6480464 Methyl Methanesulfonate results in decreased expression of ANXA1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:730873 6480464 methylmercuric chloride results in increased expression of ANXA1 mRNA CTD PMID:23179753 more ... methylparaben decreases expression ISO RGD:730873 6480464 methylparaben results in decreased expression of ANXA1 mRNA CTD PMID:31745603 miconazole decreases expression EXP 6480464 Miconazole results in decreased expression of ANXA1 mRNA CTD PMID:22262564 mifepristone multiple interactions ISO RGD:730873 6480464 Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]] more ... CTD PMID:10807665 , PMID:25763180 mifepristone increases expression ISO RGD:730873 6480464 Mifepristone results in increased expression of ANXA1 mRNA CTD PMID:17584828 monosodium L-glutamate decreases expression ISO RGD:10164 6480464 Sodium Glutamate results in decreased expression of ANXA1 mRNA CTD PMID:22078008 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ANXA1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA1 mRNA more ... CTD PMID:18164116 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ANXA1 mRNA, Diethylnitrosamine results in increased expression of ANXA1 protein CTD PMID:19638242 , PMID:20935162 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ANXA1 mRNA CTD PMID:25380136 nickel sulfate increases expression ISO RGD:730873 6480464 nickel sulfate results in increased expression of ANXA1 mRNA CTD PMID:16314067 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ANXA1 mRNA CTD PMID:26776438 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ANXA1 mRNA CTD PMID:23358140 ouabain affects expression ISO RGD:730873 6480464 Ouabain affects the expression of ANXA1 protein CTD PMID:17268060 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ANXA1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:10164 6480464 Ozone results in increased expression of ANXA1 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:10164 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ANXA1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ANXA1 mRNA CTD PMID:34911549 ozone multiple interactions ISO RGD:730873 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ANXA1 mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid increases expression ISO RGD:730873 6480464 p-Chloromercuribenzoic Acid results in increased expression of ANXA1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:730873 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA CTD PMID:27188386 paclitaxel increases response to substance ISO RGD:730873 6480464 ANXA1 protein results in increased susceptibility to Paclitaxel CTD PMID:16734730 panobinostat increases expression ISO RGD:730873 6480464 panobinostat results in increased expression of ANXA1 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:10164 6480464 Acetaminophen results in increased expression of ANXA1 mRNA CTD PMID:18544908 paracetamol increases expression ISO RGD:730873 6480464 Acetaminophen results in increased expression of ANXA1 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:10164 6480464 Acetaminophen affects the expression of ANXA1 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ANXA1 mRNA, Paraquat results in increased expression of ANXA1 protein CTD PMID:24521700 , PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10164 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ANXA1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ANXA1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ANXA1 mRNA CTD PMID:16221955 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA1 protein CTD PMID:20935162 phenobarbital affects expression ISO RGD:730873 6480464 Phenobarbital affects the expression of ANXA1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:730873 6480464 Phenylmercuric Acetate results in increased expression of ANXA1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:730873 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ANXA1 mRNA CTD PMID:12376462 phorbol 13-acetate 12-myristate increases expression ISO RGD:10164 6480464 Tetradecanoylphorbol Acetate results in increased expression of ANXA1 mRNA CTD PMID:19945525 phosgene affects expression ISO RGD:10164 6480464 Phosgene affects the expression of ANXA1 mRNA CTD PMID:16300373 potassium chloride multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of ANXA1 mRNA CTD PMID:22228705 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of ANXA1 protein CTD PMID:18563748 Propiverine affects binding EXP 6480464 propiverine binds to ANXA1 protein CTD PMID:29273565 prostaglandin E2 multiple interactions ISO RGD:730873 6480464 ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone] CTD PMID:21777521 quercetin multiple interactions ISO RGD:730873 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of ANXA1 mRNA CTD PMID:17639512 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ANXA1 mRNA CTD PMID:18095365 quercetin increases expression ISO RGD:730873 6480464 Quercetin results in increased expression of ANXA1 protein CTD PMID:15221776 quinoline increases expression ISO RGD:730873 6480464 quinoline analog results in increased expression of ANXA1 protein CTD PMID:18645022 rac-lactic acid increases expression ISO RGD:730873 6480464 Lactic Acid results in increased expression of ANXA1 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:10164 6480464 resveratrol results in decreased expression of ANXA1 protein CTD PMID:25505154 rimonabant multiple interactions ISO RGD:10164 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ANXA1 mRNA] CTD PMID:19030233 rofecoxib affects expression ISO RGD:730873 6480464 rofecoxib affects the expression of ANXA1 mRNA CTD PMID:17070997 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ANXA1 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:730873 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 senecionine increases expression ISO RGD:10164 6480464 senecionine results in increased expression of ANXA1 protein CTD PMID:35357534 silicon dioxide affects secretion ISO RGD:730873 6480464 Silicon Dioxide analog affects the secretion of ANXA1 protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:10164 6480464 Silicon Dioxide results in increased expression of ANXA1 mRNA CTD PMID:23221170 silver atom increases expression ISO RGD:730873 6480464 Silver results in increased expression of ANXA1 mRNA CTD PMID:28959546 silver(0) increases expression ISO RGD:730873 6480464 Silver results in increased expression of ANXA1 mRNA CTD PMID:28959546 simvastatin increases expression ISO RGD:10164 6480464 Simvastatin results in increased expression of ANXA1 protein CTD PMID:14973129 sodium arsenite increases expression ISO RGD:730873 6480464 sodium arsenite results in increased expression of ANXA1 protein CTD PMID:15899475 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ANXA1 protein CTD PMID:29459688 sodium arsenite decreases expression ISO RGD:10164 6480464 sodium arsenite results in decreased expression of ANXA1 protein CTD PMID:29044176 sodium fluoride increases expression ISO RGD:10164 6480464 Sodium Fluoride results in increased expression of ANXA1 protein CTD PMID:27548804 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of ANXA1 mRNA CTD PMID:30047161 sulforaphane increases expression ISO RGD:730873 6480464 sulforaphane results in increased expression of ANXA1 mRNA CTD PMID:26833863 sunitinib decreases expression ISO RGD:730873 6480464 Sunitinib results in decreased expression of ANXA1 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:730873 6480464 T-2 Toxin results in decreased expression of ANXA1 protein CTD PMID:34581912 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of ANXA1 CTD PMID:20484890 tanespimycin increases expression ISO RGD:730873 6480464 tanespimycin results in increased expression of ANXA1 protein CTD PMID:31370342 tetrachloromethane multiple interactions ISO RGD:10164 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ANXA1 mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:10164 6480464 Carbon Tetrachloride results in increased expression of ANXA1 mRNA CTD PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of ANXA1 protein CTD PMID:35544339 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA1 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANXA1 mRNA CTD PMID:34492290 thiophenes multiple interactions ISO RGD:730873 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of ANXA1 mRNA] CTD PMID:16140955 titanium dioxide multiple interactions ISO RGD:10164 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANXA1 mRNA CTD PMID:29950665 torcetrapib increases expression ISO RGD:730873 6480464 torcetrapib results in increased expression of ANXA1 mRNA CTD PMID:23228038 triadimefon decreases expression ISO RGD:730873 6480464 triadimefon results in decreased expression of ANXA1 mRNA CTD PMID:26705709 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ANXA1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:730873 6480464 trichostatin A results in increased expression of ANXA1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:730873 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA CTD PMID:27188386 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of ANXA1 mRNA CTD PMID:30589522 troglitazone increases expression ISO RGD:10164 6480464 troglitazone results in increased expression of ANXA1 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:10164 6480464 Tungsten results in decreased expression of ANXA1 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:730873 6480464 Tunicamycin results in increased expression of ANXA1 mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:730873 6480464 Valproic Acid affects the expression of ANXA1 mRNA CTD PMID:25979313 , PMID:26072468 valproic acid increases expression ISO RGD:730873 6480464 Valproic Acid results in increased expression of ANXA1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:10164 6480464 Valproic Acid affects the expression of ANXA1 mRNA CTD PMID:26072468 valproic acid decreases methylation ISO RGD:730873 6480464 Valproic Acid results in decreased methylation of ANXA1 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:10164 6480464 Vancomycin results in decreased expression of ANXA1 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANXA1 mRNA CTD PMID:19015723 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of ANXA1 promoter CTD PMID:20927350 vincristine increases expression ISO RGD:730873 6480464 Vincristine results in increased expression of ANXA1 mRNA CTD PMID:23649840 XAV939 multiple interactions ISO RGD:730873 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA CTD PMID:34480604 zinc atom affects expression ISO RGD:730873 6480464 Zinc affects the expression of ANXA1 mRNA CTD PMID:16979875 zinc(0) affects expression ISO RGD:730873 6480464 Zinc affects the expression of ANXA1 mRNA CTD PMID:16979875
